awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-57E510CE-8FD2-49DC-92E2-EE40632C4F9D
Q42720284-57E510CE-8FD2-49DC-92E2-EE40632C4F9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-57E510CE-8FD2-49DC-92E2-EE40632C4F9D
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P921
Q42720284-57E510CE-8FD2-49DC-92E2-EE40632C4F9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-57E510CE-8FD2-49DC-92E2-EE40632C4F9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d288c573e0815fdee5d227e5f0b3a8dac77256a
P921
ruxolitinib